EDIT

Welcome to the Brand page for “EDIT”, which is offered here for Pharmaceutical preparations; reagents, nucleic acids, and nucleotides for medical and veterinary purposes;reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modifications for use in the fields of scientific research, clinical research, and scientific diagnostics research;.

Its status is currently believed to be active. Its class is unavailable. “EDIT” is believed to be currently owned by “Saliogen Therapeutics, Inc.”